Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04138706Phase 3Completed
Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection
Clostridium Difficile Infection
PrincipalinvestigatorStart date: 2020-11-19

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

McGill University Health Centre/Research Institute of the McGill University Health Centre

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04138706Phase 3PrincipalInvestigator

Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection
Completed
NCT03272607Not ApplicablePrincipalInvestigator

Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention

Adverse Drug Event
Completed

All 2 trials loaded